Michelson Diagnostics Announces Development of In-Vivo OCT Probes
Press Release: For immediate release
17 March 2008
Michelson Diagnostics Announces Development of In-Vivo OCT probes
(177 Words) Cancer imaging technology company Michelson Diagnostics Ltd (MDL) has announced that it has commenced the engineering phase of its development of probes for in-vivo imaging with optical coherence tomography (OCT).
According to MDL Applications Director Dr Gordon McKenzie, more than one type of probe will start clinical testing during 2008. The probes will be suitabl
Read Full Article
Login to comment.